Sequana Medical NV (SEQUA.BR)
EUR 0.72
(3.43%)
EUR 0.72
(3.43%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -29.49 Million EUR | -3.89% |
| 2022 | -28.38 Million EUR | -25.33% |
| 2021 | -22.64 Million EUR | -26.72% |
| 2020 | -17.87 Million EUR | -27.03% |
| 2019 | -14.07 Million EUR | -7.92% |
| 2018 | -13.03 Million EUR | -72.2% |
| 2017 | -7.57 Million EUR | 44.91% |
| 2016 | -13.74 Million EUR | -20.31% |
| 2015 | -11.42 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -4.86 Million EUR | 0.0% |
| 2024 Q1 | -4.86 Million EUR | 29.77% |
| 2023 Q1 | -7.7 Million EUR | 49.02% |
| 2023 Q3 | -7.03 Million EUR | 53.89% |
| 2023 Q4 | -6.93 Million EUR | 1.49% |
| 2023 Q2 | -15.26 Million EUR | -97.98% |
| 2023 FY | -29.75 Million EUR | -4.81% |
| 2022 Q2 | -13.16 Million EUR | -98.11% |
| 2022 Q4 | -15.11 Million EUR | -97.16% |
| 2022 FY | -28.38 Million EUR | -25.33% |
| 2022 Q1 | -6.64 Million EUR | 46.07% |
| 2022 Q3 | -7.66 Million EUR | 41.73% |
| 2021 Q1 | -5.74 Million EUR | 35.18% |
| 2021 FY | -22.64 Million EUR | -26.72% |
| 2021 Q4 | -12.31 Million EUR | -99.72% |
| 2021 Q3 | -6.16 Million EUR | 45.37% |
| 2021 Q2 | -11.28 Million EUR | -96.63% |
| 2020 Q4 | -8.85 Million EUR | -100.33% |
| 2020 Q3 | -4.42 Million EUR | 48.56% |
| 2020 Q1 | -4.46 Million EUR | 37.45% |
| 2020 Q2 | -8.59 Million EUR | -92.58% |
| 2020 FY | -17.87 Million EUR | -27.03% |
| 2019 FY | -14.07 Million EUR | -7.92% |
| 2019 Q4 | -7.13 Million EUR | -100.32% |
| 2019 Q3 | -3.56 Million EUR | 43.41% |
| 2019 Q2 | -6.29 Million EUR | -84.13% |
| 2019 Q1 | -3.41 Million EUR | 32.94% |
| 2018 Q4 | -5.09 Million EUR | -43.1% |
| 2018 Q2 | -2.38 Million EUR | 0.0% |
| 2018 FY | -13.03 Million EUR | -72.2% |
| 2018 Q1 | -2.38 Million EUR | -45.71% |
| 2018 Q3 | -3.56 Million EUR | -49.6% |
| 2017 Q4 | -1.63 Million EUR | 18.04% |
| 2017 Q3 | -1.99 Million EUR | 0.0% |
| 2017 FY | -7.57 Million EUR | 44.91% |
| 2016 FY | -13.74 Million EUR | -20.31% |
| 2015 FY | -11.42 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Affluent Medical SA | -13.06 Million EUR | -125.712% |
| Bluelinea Société Anonyme | -1.61 Million EUR | -1728.743% |
| Carmat SA | -52.51 Million EUR | 43.846% |
| Diagnostic Medical Systems S.A. | -2.26 Million EUR | -1202.052% |
| Euromedis Groupe | -5.55 Million EUR | -430.69% |
| Eurobio Scientific Société anonyme | 10.14 Million EUR | 390.814% |
| Ikonisys S.A. | -2.19 Million EUR | -1244.353% |
| Implanet S.A. | -6.15 Million EUR | -378.835% |
| Median Technologies SA | -23 Million EUR | -28.19% |
| SpineGuard SA | -3.97 Million EUR | -641.719% |
| Theraclion SA | -3.15 Million EUR | -835.05% |
| Euroapi S.A. | -234.3 Million EUR | 87.413% |
| Guerbet SA | 38.67 Million EUR | 176.263% |
| Ion Beam Applications SA | 5.09 Million EUR | 679.173% |
| Koninklijke Philips N.V. | -115 Million EUR | 74.355% |